Chemours Q2 sales flat as lower volumes weigh on results
Chemours Q2 sales flat as lower volumes weigh on results
Overview
US industrial chemicals maker's Q2 sales were flat yr/yr and missed analyst expectations
Adjusted EPS for Q2 met analyst expectations
Adjusted net income and adjusted EBITDA for Q2 beat analyst estimates
Outlook
Chemours expects Q3 adjusted EBITDA between $175 mln and $205 mln
Company maintains 2026 adjusted EBITDA outlook of $775 mln to $825 mln
Chemours sees 2026 net sales growing 1% to 5% over 2025
Result Drivers
VOLUME DECLINES - Co said lower volumes, particularly in TSS aftermarket refrigerants and APM due to a line closure, weighed on sales
PRICING ACTIONS - Price increases across all segments, especially in Titanium Technologies, helped offset volume declines
HIGHER COSTS - Adjusted EBITDA was impacted by higher costs related to a resolved outage at the Washington Works site and lower sales from the APM line closure
Company press release: ID:nPn7zhylna
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales | Miss | $1.60 bln | $1.65 bln (7 Analysts) |
Q2 Adjusted EPS | Meet | $0.42 | $0.42 (9 Analysts) |
Q2 Loss Per Share |
| $1.81 |
|
Q2 Adjusted Net Income | Beat | $64 mln | $60.68 mln (6 Analysts) |
Q2 Adjusted EBITDA | Beat | $247 mln | $238.07 mln (8 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy."
Wall Street's median 12-month price target for Chemours Co is $25.50, about 49% above its August 3 closing price of $17.11
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 16 three months ago
Reuters Recommended Reads
Aug 4 - DuPont narrows annual sales forecast on water business weakness, shares down
Aug 4 - Celanese Q2 adjusted EPS beats estimates, sales meet expectations
Aug 4 - Germany's Evonik Q2 revenue up 11% on higher volumes and prices
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on The Chemours
See all newsUS RESEARCH ROUNDUP-Essex Property Trust, Qualys, Vulcan Materials
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals'
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval